Evidence map›Paper›PMID 30901492›Full record

ArticleMovement disorders : official journal of the Movement Disorder Society2019

The Parkinson's disease e-diary: Developing a clinical and research tool for the digital age.

Joaquin A Vizcarra, Álvaro Sánchez-Ferro, Walter Maetzler, Luca Marsili, Lucia Zavala, Anthony E Lang, Pablo Martinez-Martin, Tiago A Mestre, Ralf Reilmann, Jeffrey M Hausdorff and 19 more

Abstract read
In one paragraph

Article in Movement disorders : official journal of the Movement Disorder Society, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Translating Evidence to Advanced Parkinson's Disease Patients: A Systematic Review and Meta-Analysis.Movement disorders : official journal of the Movement Disorder Society · 2021
    Pooled it
  2. Article
  3. Article
  4. Article
  5. Effect of Flavonoids against Parkinson's Disease.Central nervous system agents in medicinal chemistry · 2024
    Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

29 authors.

Joaquin A VizcarraGardner Family Center for Parkinson's Disease and Movement Disorders, Department of Neurology, University of Cincinnati, Cincinnati, Ohio, USA.
Álvaro Sánchez-FerroHM CINAC, Hospital Universitario HM Puerta del Sur, Móstoles, Madrid, Spain.ORCID 0000-0003-2461-2485
Walter MaetzlerDepartment of Neurology, University of Kiel, Kiel, Germany.
Luca MarsiliGardner Family Center for Parkinson's Disease and Movement Disorders, Department of Neurology, University of Cincinnati, Cincinnati, Ohio, USA.
Lucia ZavalaHospital General de Agudos Jose Maria Ramos Mejia, Departamento de Neurología, Universidad de Buenos Aires, Buenos Aires, Argentina.
Anthony E LangThe Edmond J. Safra Program in Parkinson's Disease and the Morton and Gloria Shulman Movement Disorders Clinic, University of Toronto, Toronto, Ontario, Canada.ORCID 0000-0003-1229-3667
Pablo Martinez-MartinNational Center of Epidemiology and CIBERNED, Carlos III Institute of Health, Madrid, Spain.
Tiago A MestreParkinson's Disease and Movement Disorders Center, Division of Neurology, Department of Medicine, The Ottawa Hospital Research Institute, University of Ottawa, Ottawa, Ontario, Canada.ORCID 0000-0002-6973-7479
Ralf ReilmannGeorge Huntington Institute and Dept. of Clinical Radiology, University of Muenster, Muenster, and Dept. of Neurodegenerative Diseases and Hertie Institute for Clinical Brain Research, University of Tuebingen, Tuebingen, Germany.ORCID 0000-0002-5904-9517
Jeffrey M HausdorffCenter for the Study of Movement, Cognition, and Mobility, Tel Aviv Sourasky Medical Center; Department of Physical Therapy, Sackler Faculty of Medicine and Sagol School of Neuroscience, Tel Aviv University, Israel; Rush Alzheimer's Disease Center and Department of Orthopaedic Surgery, Rush University Medical Center, Chicago, Illinois, USA.
E Ray DorseyDepartment of Neurology and Center for Health + Technology, University of Rochester Medical Center, Rochester, New York, USA.
Serene S PaulDiscipline of Physiotherapy, Faculty of Health Sciences, University of Sydney, Sydney, Australia.
Judith W DexheimerDepartment of Biomedical Informatics, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA.
Benjamin D WisselGardner Family Center for Parkinson's Disease and Movement Disorders, Department of Neurology, University of Cincinnati, Cincinnati, Ohio, USA.
Rebecca L M FullerCHDI Foundation/ CHDI Management, Inc., Princeton, New Jersey, USA.
Paolo BonatoDepartment of Physical Medicine & Rehabilitation, Spaulding Rehabilitation Hospital, Harvard Medical School, Charlestown, Massachusetts, USA.
Ai Huey TanDivision of Neurology and the Mah Pooi Soo & Tan Chin Nam Centre for Parkinson's & Related Disorders, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia.
Bastiaan R BloemRadboud University Medical Center, Donders Institute for Brain, Cognition and Behaviour, Department of Neurology, Nijmegen, The Netherlands.
Catherine KopilThe Michael J. Fox Foundation for Parkinson's Research, New York, New York, USA.
Margaret DaeschlerThe Michael J. Fox Foundation for Parkinson's Research, New York, New York, USA.
Lauren BatailleThe Michael J. Fox Foundation for Parkinson's Research, New York, New York, USA.
Galit KleinerJeff and Diane Ross Movement Disorders Clinic at ATC/Baycrest Health Sciences, Division of Neurology Department of Medicine University of Toronto, Toronto, Ontario, Canada.
Jesse M CedarbaumBiogen, Cambridge, Massachusetts, USA.
Jochen KluckenDepartment of Molecular Neurology, Movement Disorder Unit, University Hospital Erlangen, Friedrich-Alexander-University Erlangen-Nürnberg, Erlangen, Germany.
Aristide MerolaGardner Family Center for Parkinson's Disease and Movement Disorders, Department of Neurology, University of Cincinnati, Cincinnati, Ohio, USA.ORCID 0000-0002-5587-726X
Christopher G GoetzDepartment of Neurological Sciences, Rush University Medical Center, Chicago, Illinois, USA.
Glenn T StebbinsDepartment of Neurological Sciences, Rush University Medical Center, Chicago, Illinois, USA.
Alberto J EspayGardner Family Center for Parkinson's Disease and Movement Disorders, Department of Neurology, University of Cincinnati, Cincinnati, Ohio, USA.ORCID 0000-0002-3389-136X
MDS Technology Task Force and the MDS Rating Scales Program Electronic Development Ad-Hoc Committee

Funding

Medical Scientist Training ProgramT32GM063483 · NIGMS · UNIVERSITY OF CINCINNATI · PI KHURANA HERSHEY, GURJIT K. · 2002 to 2022
$6.7M
NIGMS NIH HHS T32 GM063483
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Mobile ApplicationsPatient Outcome AssessmentPatient Reported Outcome MeasuresWearable Electronic DevicesData VisualizationHumansParkinson Disease

Identifiers

PMID30901492
PMCPMC8114172

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.